C12Y 306/01003
Adenosine triphosphatase
Official title: Adenosine triphosphatase (3.6.1.3)
C12Y306/01003 (Adenosine triphosphatase) appears on 25 US grants and 46 published applications in this corpus.
Search patents in C12Y- Granted patents
- 25
- Published applications
- 46
- Assignees
- 36
- Inventors
- 93
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 3 |
| 2011 | 0 | 2 |
| 2012 | 0 | 1 |
| 2013 | 3 | 1 |
| 2014 | 0 | 3 |
| 2015 | 0 | 5 |
| 2016 | 2 | 4 |
| 2017 | 2 | 5 |
| 2018 | 3 | 3 |
| 2019 | 0 | 2 |
| 2020 | 2 | 5 |
| 2021 | 5 | 6 |
| 2022 | 2 | 1 |
| 2023 | 2 | 1 |
| 2024 | 2 | 4 |
| 2025 | 1 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Use of HSP70 as a regulator of enzymatic activity17 Mar 2026US 12,576,076 B2Zevra Denmark A/S
- Disease treatment drug based on mesenchymal-stem-cell mobilization20 May 2025US 12,304,933 B2Osaka University
- Inhibitors of the Notch transcriptional activation complex kinase (“NACK”) and methods for use of the same3 Sep 2024US 12,077,508 B2University of Miami
- Use of Hsp70 as a regulator of enzymatic activity26 Mar 2024US 11,938,125 B2Zevra Denmark A/S
- Inhibitors of the notch transcriptional activation complex kinase (“NACK”) and methods for use of the same16 May 2023US 11,649,214 B2University of Miami
- Disease Treatment Drug Based on Mesenchymal-Stem-Cell Mobilization7 Nov 2024US 2024/0368235 A1Osaka University
- Chaperones as an autophagy receptors for clearances of protein aggregates and/or aggregation-prone proteins24 Oct 2024US 2024/0350586 A1Tsinghua University
- Use of hsp70 as a regulator of enzymatic activity19 Sep 2024US 2024/0307366 A1Zevra Denmark A/S
- Plant body of genus nicotiana and production method therefor1 Feb 2024US 2024/0032498 A1Japan Tobacco Inc.
- Inhibitors of the notch transcriptional activation complex kinase ("nack") and methods for use of the same13 Apr 2023US 2023/0113546 A1University of Miami
Most cited
By later US patents
- Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside16US 8,367,363 B2Phoenix Biotechnology, Inc. · 2013
- Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside12US 9,494,589 B2Phoenix Biotechnology, Inc. · 2016
- Use of HSP70 as a regulator of enzymatic activity8US 9,289,472 B2Orphazyme ApS · 2016
- Use of Hsp70 as a regulator of enzymatic activity6US 9,884,058 B2Orphazyme ApS · 2018
- Use of Hsp70 as a regulator of enzymatic activity5US 10,543,204 B2Orphazyme A/S · 2020